Schedule a briefing
Biotech and Pharma

Request the Biotech and Pharma white paper.

GxP-ready sovereign compute co-located with the lab or the plant.

Qualified request

Biotech and Pharma white paper

The Biotech and Pharma paper covers the capabilities ER Vault™ brings to your sector - deployment path, compliance posture, and the questions your buying committee will ask. Delivered by email within one business day after a short qualification.

Request by email

Prefer a conversation first? Schedule a briefing instead ›

Frequently asked

Biotech and Pharma questions, answered.

Is ER Vault GxP-ready?

Yes. The platform is built to support 21 CFR Part 11 electronic-records and signatures obligations, GAMP 5 validation posture, and the audit-trail requirements regulators expect for GLP, GCP, and GMP workloads.

Why does model sovereignty matter for biotech?

A model trained on a sponsor's trial data, assay data, or process data is itself IP. Running that training inside a hyperscaler region means the model lives on infrastructure the sponsor does not control. ER Vault keeps both data and weights on customer-owned hardware.

Can we integrate with existing LIMS and ELN systems?

Yes. ER Cyber Membrane ingress patterns exist for Benchling, LabWare, LabVantage, STARLIMS, and custom LIMS, plus the common instrument vendors.

How does ER Vault handle PHI de-identification?

De-identification and tokenization run on the vault itself before any training or inference, so raw PHI never crosses a boundary and the audit trail captures each transformation.